Sunitinib for the treatment of gastrointestinal stromal tumours

  • Technology appraisal guidance
  • TA179
  • Published: 
Download guidance (PDF)

6 Recommendations for further research

6.1

A trial comparing 37.5 mg sunitinib with 800 mg imatinib is currently recruiting participants.

6.2

The committee considered that rigorous data collection is needed on the life-extending benefits of sunitinib.